Cancer
Malignant Lung Neoplasm
CI-CAN-00001140Explore in graph →
Top-level2,650 active trials51 approved drugs619 evidence items
- NCIt
- C7377
- ICD-10
- C33-C34
- DOID
- 1324
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001140Explore in graph →
Clinical trials
11,125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,491)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00818675 | A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1) | terminated | Phase 2 | 80 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jan 21, 2015 | clinicaltrials |
| NCT01046383 | Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients | terminated | Phase 3 | 16 | Immunotec Inc.INDUSTRY | 1 | Jan 21, 2015 |
| NCT00511576 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | terminated | Phase 1 | 54 | Mirati Therapeutics Inc.INDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT00975767 | A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer | terminated | Phase 1 | 126 | Mirati Therapeutics Inc.INDUSTRY | 1 | Jan 8, 2015 | clinicaltrials |
| NCT01761747 | Ponatinib for Squamous Cell Lung and Head and Neck Cancers | terminated | Phase 2 / Phase 3 | 3 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00452075 | Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy | terminated | Phase 2 | 24 | Rigshospitalet, DenmarkOTHER | 1 | Dec 11, 2014 | clinicaltrials |
| NCT01664663 | Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy(PLANET) | terminated | Phase 2 | 37 | Ass. Prof. Jan NymanNETWORK | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01038037 | First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer(Lung-TRIO) | terminated | Phase 2 | 23 | Vejle HospitalOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT00549328 | Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 14 | GlaxoSmithKlineINDUSTRY | 1 | Nov 19, 2014 | clinicaltrials |
| NCT00726986 | Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | terminated | Phase 2 | 18 | Afshin Dowlati, MDOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01049776 | GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line | terminated | Phase 2 | 32 | Illinois CancerCare, P.C.OTHER | 1 | Sep 19, 2014 | clinicaltrials |
| NCT02127372 | Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 | terminated | Phase 1 / Phase 2 | 43 | Duke UniversityOTHER | 0 | Sep 15, 2014 | clinicaltrials |
| NCT00509366 | Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer(TOP0602) | terminated | Phase 2 | 101 | Duke UniversityOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT02209727 | Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | terminated | Phase 1 | 9 | Boehringer IngelheimINDUSTRY | 0 | Aug 6, 2014 | clinicaltrials |
| NCT00787852 | A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 1 | 11 | Brown UniversityOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT00373204 | Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | terminated | Phase 2 | 50 | Pharmacyclics LLC.INDUSTRY | 4 | Jul 24, 2014 | clinicaltrials |
| NCT00545948 | Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer(TOP0703) | terminated | Phase 2 | 31 | Duke UniversityOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT01491633 | Dasatinib in Advanced Squamous Cell Lung Cancer | terminated | Phase 2 | 5 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 15, 2014 | clinicaltrials |
| NCT02157116 | Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 13 | Duke UniversityOTHER | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00002947 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated | Phase 1 | 35 | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00145418 | Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer | terminated | Phase 2 | 15 | Oncology Specialists, S.C.OTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT00898209 | Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE) | terminated | — | 564 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Jun 24, 2014 | clinicaltrials |
| NCT00528775 | Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages | terminated | Phase 2 | 6 | Roswell Park Cancer InstituteOTHER | 1 | Jun 10, 2014 | clinicaltrials |
| NCT00544648 | Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC | terminated | Phase 1 / Phase 2 | 13 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00004859 | Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer | terminated | Phase 3 | 589 | National Cancer Institute (NCI)NIH | 2 | Jun 2, 2014 | clinicaltrials |
| NCT00976677 | Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT00084487 | Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy | terminated | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00323362 | Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer | terminated | Phase 2 | 17 | Rutgers, The State University of New JerseyOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00614484 | Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer | terminated | Phase 1 / Phase 2 | 28 | Loma Linda UniversityOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01471197 | Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer | terminated | Phase 2 | 9 | Bristol-Myers SquibbINDUSTRY | 5 | May 12, 2014 | clinicaltrials |
| NCT00088933 | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00203931 | Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer | terminated | Phase 2 | 55 | University of ChicagoOTHER | 1 | Mar 31, 2014 | clinicaltrials |
| NCT01409681 | A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer(EBUS) | terminated | — | 41 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00101907 | Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer | terminated | Phase 1 | 41 | AmgenINDUSTRY | 0 | Mar 20, 2014 | clinicaltrials |
| NCT01617980 | Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer(HIL) | terminated | N/A | 4 | German Cancer Research CenterOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01641575 | A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin | terminated | Phase 1 | 8 | Clovis Oncology, Inc.INDUSTRY | 2 | Mar 11, 2014 | clinicaltrials |
| NCT00369551 | Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Mar 6, 2014 | clinicaltrials |
| NCT01356368 | Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer(Customizing) | terminated | Phase 2 | 3 | National Guard Health AffairsOTHER_GOV | 1 | Jan 22, 2014 | clinicaltrials |
| NCT01063478 | Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC(RAD001) | terminated | Phase 1 | 3 | University of ChicagoOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00265603 | Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer | terminated | Phase 1 | 16 | Atlantic Health SystemOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT01473693 | Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging | terminated | — | 1 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT01640730 | Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer | terminated | Phase 2 | 1 | KangLaiTe USAINDUSTRY | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00858403 | Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation | terminated | Phase 2 | 7 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 15, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT01871480 | CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer | terminated | Phase 2 | 50 | Kunming Medical UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT00856427 | Implantation of Markers for the Radiotherapy of Lung Cancer Patients | terminated | Phase 1 | 6 | Virginia Commonwealth UniversityOTHER | 1 | Dec 20, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jan 21, 2015source: clinicaltrials